Testicular Tissue Cryopreservation for Fertility Preservation
Phase NA Recruiting
1,500 enrolled
Spermatogonial Stem Cell (SSC) Transplant and Testicular Tissue Grafting
Phase NA Recruiting
10 enrolled
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
Phase 3 Recruiting
360 enrolled
HOPAYA
Phase NA Recruiting
214 enrolled
Experience and Management of Cancer Screening-Related Anxiety in Fanconi Anemia
Recruiting
20 enrolled
P300
Phase 1/2 Recruiting
252 enrolled
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Phase 2 Recruiting
100 enrolled
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
Phase 2 Recruiting
204 enrolled
A Phase IIa, Single-arm, Open-label Clinical Study to Evaluate the Efficacy, Safety and PK of CVM-1118 in Combination With Sintilimab and TACE in Participants With Incurable/Non-metastatic HCC
Phase 2 Recruiting
40 enrolled
Collection of Blood From Patients With Cancer
Recruiting
1,750 enrolled
PREMIUM
Phase NA Recruiting
4,700 enrolled
Assessment of Functional and Symptom Outcomes for Survivors of Paranasal Sinus, Nasopharyngeal and Skull Base Tumors
Recruiting
300 enrolled
Preoperative Radioimmunotherapy Versus Chemoimmunotherapy in NSCLC
Phase 2 Recruiting
112 enrolled
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
Phase 1 Recruiting
405 enrolled
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
Phase 1 Recruiting
234 enrolled
PERTUREAL
Recruiting
1,000 enrolled
Prediction of Postoperative ICU Requirement in Oncologic Surgery
Recruiting
500 enrolled
(NYCBS)
Recruiting
900,000 enrolled
STATIC
Phase NA Recruiting
80 enrolled
Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
Recruiting
1,029 enrolled
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
Recruiting
5,950 enrolled
Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer
Recruiting
950 enrolled
Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
Recruiting
6,035 enrolled
Tumor Related Epilepsy
Recruiting
100 enrolled
Sample Collection and Tracking for the Developmental Therapeutics Clinic
Recruiting
3,000 enrolled
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
Phase 1 Recruiting
65 enrolled
Longitudinal Studies of Patient With FPDMM
Recruiting
1,000 enrolled
R37
Phase NA Recruiting
6,516 enrolled
ReplaceCysto
Phase 2 Recruiting
240 enrolled
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Phase 3 Recruiting
750 enrolled
SUNRAY-01
Phase 3 Recruiting
1,264 enrolled
NST-628
Phase 1 Recruiting
230 enrolled
SAFE ESO
Phase 2 Recruiting
95 enrolled
A Phase II Clinical Study Evaluating the Effectiveness of Injectable NC527-X in Intraoperative Imaging for Patients With Solid Tumors
Phase 1 Recruiting
400 enrolled
Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer
Recruiting
1,100 enrolled
SPECTA
Recruiting
4,975 enrolled
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated With Radiation
Recruiting
10,000 enrolled
A New Psychotherapy Intervention for Older Cancer Patients
Phase NA Recruiting
459 enrolled
OncoBRAIN
Phase NA Recruiting
60 enrolled
SaLuDo
Phase 3 Recruiting
450 enrolled
Tumor HI
Phase 3 Recruiting
16 enrolled
A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment BNT327 and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer
Phase 1/2 Recruiting
482 enrolled
A Study of PHN-012 in Patients With Advanced Solid Tumors
Phase 1 Recruiting
165 enrolled
KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)
Phase 2 Recruiting
130 enrolled
A Study of [18F]LY4214835 in Healthy Volunteers and Participants With Cancer
Phase 1 Recruiting
41 enrolled
MK-3475-G21
Phase 1/2 Recruiting
20 enrolled
CLIQQC
Recruiting
2,000 enrolled
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Phase 1/2 Recruiting
152 enrolled
Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases
Phase 2 Recruiting
104 enrolled
A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations
Phase 1/2 Recruiting
96 enrolled